POSEIDA Trademark

Trademark Overview


On Wednesday, April 21, 2021, a trademark application was filed for POSEIDA with the United States Patent and Trademark Office. The USPTO has given the POSEIDA trademark a serial number of 90660241. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Poseida Therapeutics, Inc.. The POSEIDA trademark is filed in the Chemical Products category with the following description:

Kits comprised of genetically engineered cell lines, reagents, enzyme substrates and chemical preparations for research purposes; reagents and kits comprising reagents for research use in connection with cell manipulation, cell transformation, genomic editing and analysis; reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research
poseida

General Information


Serial Number90660241
Word MarkPOSEIDA
Filing DateWednesday, April 21, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Translation of Words in MarkThe English translation of the word "poseida" in the mark is "possessed".
Goods and ServicesKits comprised of genetically engineered cell lines, reagents, enzyme substrates and chemical preparations for research purposes; reagents and kits comprising reagents for research use in connection with cell manipulation, cell transformation, genomic editing and analysis; reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, July 28, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePoseida Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NamePoseida Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Saturday, April 24, 2021NEW APPLICATION ENTERED
Wednesday, July 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 15, 2021ASSIGNED TO EXAMINER
Friday, December 17, 2021EXAMINERS AMENDMENT -WRITTEN
Sunday, December 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 17, 2021EXAMINER'S AMENDMENT ENTERED
Friday, December 17, 2021EXAMINERS AMENDMENT E-MAILED
Friday, December 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 22, 2022SOU EXTENSION 1 FILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 1 GRANTED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023SOU EXTENSION 2 FILED
Thursday, February 23, 2023SOU EXTENSION 2 GRANTED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 3 FILED
Wednesday, August 16, 2023SOU EXTENSION 3 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024SOU EXTENSION 5 FILED
Wednesday, September 11, 2024SOU EXTENSION 5 GRANTED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 4 FILED
Tuesday, March 12, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED